BioCentury
ARTICLE | Company News

Celltech to buy Thiemann

September 12, 2001 7:00 AM UTC

Celltech (LSE:CCH; CLL) will purchase Thiemann and its Thiemann Arzneimittel pharmaceutical sales and marketing subsidiary (Waltrop, Germany) for L31 million ($45.26 million) in cash. Thiemann markets...